A synthetic peptide corresponding to residues in Human TRAPPC2.
This product is a recombinant rabbit monoclonal antibody.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Our Abpromise guarantee covers the use of ab111848 in the following tested applications.
|WB||1/1000 - 1/10000. Predicted molecular weight: 16 kDa.|
ab111848 has not yet been referenced specifically in any publications.